Staff Profile

Current role

I joined the PHSI (former IHS) Biostatistics Research Group in August 2017. Before joining the group, I was working as a Medical Statistician within the School of Medicine, Pharmacy & Health, Durham University, Queen’s campus. I completed my Postgraduate degree and PhD at the Interuniversity Institute for Biostatistics and statistical Bioinformatics for statistics, Hasselt University, Belgium. My research mainly focused on the integration of multi-source data in the development of clinical biomarker/surrogate. Currently, most of my work is relate to adaptive design clinical trial projects. 

Postgraduate Teaching

MSc Public Health and Health Services Research: HSC8036 Health Statistics

Research Interests

My research interests lie within the field of statistics, and include:

- Analysis of longitudinal data / repeated measures

- Survival analysis

- Classification / Discrimination

- Integration of multi-source data in the development of clinical

  biomarker/surrogate.

- Adaptive designs for clinical trials.

-Risk prediction and prognostic models 

• Articles

  • Mamasoula C, Bigirumurame T, Chadwick T, Addor M-C, Cavero-Carbonell C, Dias CM, Echevarria-Gonzalez-de-Garibay L-J, Gatt M, Khoshnood B, Klungsoyr K, Randall K, Stoianova S, Haeusler M, Nelen V, Neville AJ, Perthus I, Pierini A, Bertaut-Nativel B, Rissmann A, Rouget F, Schaub B, Tucker D, Wellesley D, Zymak-Zakutnia N, Barisic I, de Walle HEK, Lanzoni M, Sayers G, Mullaney C, Pennington L, Rankin J. Maternal age and the prevalence of congenital heart defects in Europe, 1995–2015: A register-based study. Birth Defects Research 2023, epub ahead of print.
  • Bigirumurame T, Uwimpuhwe G, Wason J. Sequential multiple assignment randomized trial studies should report all key components: a systematic review. Journal of Clinical Epidemiology 2022, 142, 152-160.
  • Hiu SKW, Bigirumurame T, Kunonga P, Bryant A, Pillai M. Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer;s disease: A systematic review and meta-analysis. Brain and Behavior 2022, epub ahead of print.
  • Heslehurst N, Ngongalah L, Bigirumurame T, Nguyen TG, Odeniyi A, Flynn A, Smith V, Crowe L, Skidmore B, Gaudet L, Simon A, Hayes L. Association between maternal adiposity measures and adverse maternal outcomes of pregnancy: systematic review and meta-analysis. Obesity Reviews 2022, 23(7), e13449.
  • Abouhajar A, Alcock L, Bigirumurame T, Bradley P, Brown L, Campbell I, Del Din S, Faitg J, Falkous G, Gorman GS, Lakey R, McFarland R, Newman J, Rochester L, Ryan V, Smith H, Steel A, Stefanetti RJ, Su H, Taylor RW, Thomas NJP, Tuppen H, Vincent AE, Warren C, Watson G. Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy. Trials 2022, 23(1), 789.
  • Grayling MJ, Bigirumurame T, Cherlin S, Ouma L, Zheng H, Wason JMS. Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC Rheumatology 2021, 5, 21.
  • Slight SP, Tolley CL, Bates DW, Fraser R, Bigirumurame T, Kasim A, Balaskonis K, Narrie S, Heed A, Orav EJ, Watson NW. Medication errors and adverse drug events in a UK hospital during the optimisation of electronic prescriptions: a prospective observational study. The Lancet Digital Health 2019, 1(8), E403-E412.
  • Jameson SS, Asaad A, Diament M, Kasim A, Bigirumurame T, Baker P, Mason J, Partington P, Reed M. Antibiotic-loaded bone cement is associated with a lower risk of revision following primary cemented total knee arthroplasty: an analysis of 731,214 cases using National Joint Registry data. The Bone & Joint Journal 2019, 101-B(11), 1331-1347.
  • Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, Lohse AW, Heneghan MA, Jones DEJ. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Alimentary Pharmacology and Therapeutics 2018, 48(9), 951-960.
  • Bigirumurame T, Kasim A. Can testing clinical significance reduce false positive rates in randomized controlled trials? A snap review. BMC Research Notes 2017, 10, 775.
  • Louis E, Adriaensens P, Guedens W, Bigirumurame T, Baeten K, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, Shkedy Z, Mesotten L, Thomeer M. Detection of lung cancer via metabolic changes measured in blood plasma. Journal of Thoracic Oncology 2016, 11(4), 516–523.
  • Bigirumurame T, Thilakarathne PJ, Louis E, Bervoets L, Vanhove K, deJonge E, Thomeer M, Mesotten L, Stinissen P, Vanderzande D, Shkedy Z, Kasim A, Adriaensens P. Analysis and Statistical Validation of H-NMR Metabolite Profiles for Early Detection of Breast Cancer. Journal of Data Mining and Bioinformatics 2016. Submitted.
  • Verbist B, Klambauer G, Vervoort L, Talloen W, Shkedy Z, Thas O, Bender A, Göhlmann HWH, Hochreiter S, Bigirumurame T. Using transcriptomics to guide lead optimization in drug discovery projects:Lessons learned from the QSTAR project. Drug Discovery Today 2015, 20(5), 505-513.

• Conference Proceedings (inc. Abstracts)

  • Brennan-Tovey K, Aquino MRJ, Flanagan S, Kaner E, Wearn A, Bigirumurame T, Fong M, Todd A, Aveyard P, Jolly K, Damery S, Attwood A, Robson D, West J, Bridges S, Armitage CJ, Russell S, Strong S, Ramsay SE. Implementation of the NHS-funded tobacco dependence services in England: a qualitative study to understand the contexts of implementation. In: Public Health Science 2021. 2021, Online: The Lancet Publishing Group.
  • Bigirumurame T, Perualila NJ, Shkedy Z, Adetayo K. Integrated analysis of multi-source data in drugdiscovery experiments using structural equation models. In: 30th International Workshop on Statistical Modelling. 2015, Linz, Austria.

• Edited Book

  • Alonso A, Bigirumurame T, Burzykowski T, Buyse M, Molenberghs G, Muchene L, Perualila NJ, Shkedy Z, Van der Elst W, ed. Applied Surrogate Endpoint Evaluation Methods with SAS and R. Boca Raton: Chapman & Hall/CRC, 2016.